Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8


Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University., Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.


Optimal treatment of social phobia: systematic review and meta-analysis.

Canton J, Scott KM, Glue P.

Neuropsychiatr Dis Treat. 2012;8:203-15. doi: 10.2147/NDT.S23317. Epub 2012 May 3.


Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder.

Lim SW, Kwon YS, Ha J, Yoon HG, Bae SM, Shin DW, Shin YC, Oh KS.

Psychiatry Investig. 2012 Mar;9(1):73-9. doi: 10.4306/pi.2012.9.1.73. Epub 2012 Jan 18.


Psychopharmacology of anxiety disorders.

Cassano GB, Baldini Rossi N, Pini S.

Dialogues Clin Neurosci. 2002 Sep;4(3):271-85.


A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.

Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR.

Arch Gen Psychiatry. 2010 Mar;67(3):286-95. doi: 10.1001/archgenpsychiatry.2010.11.


Toward an integrative understanding of social phobia.

Li D, Chokka P, Tibbo P.

J Psychiatry Neurosci. 2001 May;26(3):190-202. Review.


Unmasking social anxiety disorder.

Stein MB, Gorman JM.

J Psychiatry Neurosci. 2001 May;26(3):185-9. Review. No abstract available.


Supplemental Content

Support Center